Share this post on:

Product Name :
Niraparib Tosylate/Abiraterone Acetate

Search keywords :
Niraparib

drugId :
null

Target Vo:
Poly (ADP-Ribose) Polymerase 2

Target Vo Short Name :
PARP-2

Moa_Name:
Poly (ADP-Ribose) polymerase 1 inhibitors

First Approval Country :
EU

First Approval Date Filter:
2023

Origin Company_Name :
Janssen-Cilag International Nv

Active Company_Name :
Fisher Clinical Services Gmbh

Active Indication_Name:
Prostatic Neoplasms, Castration-Resistant

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Prasinezumab web
Desmin Rabbit mAb Epigenetics
ATG4A Antibody: ATG4A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to ATG4A. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human .

Share this post on:

Author: Interleukin Related